Literature DB >> 15063123

The C-terminal domain of the pVP2 precursor is essential for the interaction between VP2 and VP3, the capsid polypeptides of infectious bursal disease virus.

Ana Oña1, Daniel Luque, Fernando Abaitua, Antonio Maraver, José R Castón, Jose F Rodríguez.   

Abstract

The interaction between the infectious bursal disease virus (IBDV) capsid proteins VP2 and VP3 has been analyzed in vivo using baculovirus expression vectors. Data presented here demonstrate that the 71-amino acid C-terminal-specific domain of pVP2, the VP2 precursor, is essential for the establishment of the VP2-VP3 interaction. Additionally, we show that coexpression of the pVP2 and VP3 polypeptides from independent genes results in the assembly of virus-like particles (VLPs). This observation demonstrates that these two polypeptides contain the minimal information required for capsid assembly, and that this process does not require the presence of the precursor polyprotein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063123     DOI: 10.1016/j.virol.2004.01.025

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  25 in total

1.  VP3, a structural protein of infectious pancreatic necrosis virus, interacts with RNA-dependent RNA polymerase VP1 and with double-stranded RNA.

Authors:  Torunn Pedersen; Astrid Skjesol; Jorunn B Jørgensen
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

2.  Electrostatic interactions between capsid and scaffolding proteins mediate the structural polymorphism of a double-stranded RNA virus.

Authors:  Irene Saugar; Nerea Irigoyen; Daniel Luque; José L Carrascosa; José F Rodríguez; José R Castón
Journal:  J Biol Chem       Date:  2009-11-20       Impact factor: 5.157

3.  Intracellular interference of infectious bursal disease virus.

Authors:  Dolores González; Jose Francisco Rodríguez; Fernando Abaitua
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Host proteolytic activity is necessary for infectious bursal disease virus capsid protein assembly.

Authors:  Nerea Irigoyen; José R Castón; José F Rodríguez
Journal:  J Biol Chem       Date:  2012-05-22       Impact factor: 5.157

5.  Structure and dsRNA-binding activity of the Birnavirus Drosophila X Virus VP3 protein.

Authors:  Diego S Ferrero; Idoia Busnadiego; Damià Garriga; Pablo Guerra; María Teresa Martín; Leonor Kremer; Isabel Usón; José Francisco Rodriguez; Nuria Verdaguer
Journal:  J Virol       Date:  2020-11-25       Impact factor: 5.103

6.  Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.

Authors:  Elena Pascual; Carlos P Mata; Josué Gómez-Blanco; Noelia Moreno; Juan Bárcena; Esther Blanco; Ariel Rodríguez-Frandsen; Amelia Nieto; José L Carrascosa; José R Castón
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

7.  Nuclear factor NF45 interacts with viral proteins of infectious bursal disease virus and inhibits viral replication.

Authors:  Ruth L O Stricker; Sven-Erik Behrens; Egbert Mundt
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

8.  Structural peptides of a nonenveloped virus are involved in assembly and membrane translocation.

Authors:  Christophe Chevalier; Marie Galloux; Joan Pous; Céline Henry; Jérôme Denis; Bruno Da Costa; Jorge Navaza; Jean Lepault; Bernard Delmas
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

9.  Infectious Bursal Disease Virus Hijacks Endosomal Membranes as the Scaffolding Structure for Viral Replication.

Authors:  María Cecilia Gimenez; Flavia Adriana Zanetti; Mauricio R Terebiznik; María Isabel Colombo; Laura Ruth Delgui
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

10.  Autoproteolytic activity derived from the infectious bursal disease virus capsid protein.

Authors:  Nerea Irigoyen; Damià Garriga; Aitor Navarro; Nuria Verdaguer; José F Rodríguez; José R Castón
Journal:  J Biol Chem       Date:  2009-01-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.